Serum calprotectin as a biomarker for Crohn's disease

Journal of Crohn's and Colitis

Volumn 7, Issue 12, 2013, Pages

  Meuwis, M A ^a   Vernier Massouille, G ^b   Grimaud, J C ^c   Bouhnik, Y ^d   Laharie, D ^e   Piver, E ^f   Seidel, L ^g   Colombel, J F ^h   Louis, E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIV LILLE   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d BEAUJON HOSPITAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Crohn's disease; Infliximab; Relapse prediction; Serum calprotectin

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; CROHN'S DISEASE ENDOSCOPIC INDEX OF SEVERITY; DISEASE ACTIVITY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT RESPONSE;

BIOMARKER; CD; CDAI; CDEIS; CROHN'S DISEASE; CROHN'S DISEASE ACTIVITY INDEX; CROHN'S DISEASE ENDOSCOPIC INDEX OF SEVERITY; HIGH SENSITIVITY CRP; HSCRP; IBD; INFLAMMATORY BOWEL DISEASE; INFLIXIMAB; RELAPSE PREDICTION; SERUM CALPROTECTIN;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FECES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PREDICTIVE VALUE OF TESTS; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; WITHHOLDING TREATMENT;

EID: 84887609133     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.06.008     Document Type: Article

References (12)

1. Gebhardt C., Németh J., Angel P., Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006, 72:1622-1631.
2. Vermeire S., Van Assche G., Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 2006, 55:426-431.
3. Burri E., Beglinger C. Faecal calprotectin in the diagnosis of inflammatory bowel disease. Biochem Med (Zagreb) 2011, 21:245-253.
4. Zippi M., Al Ansari N., Siliquini F., et al. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease. Clin Ter 2010, 161:e53-e56.
5. Lewis J.D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011, 140:1817-1826. [e2].
6. Mao R., Xiao Y.L., Gao X., et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies. Inflamm Bowel Dis 2012, 18:1894-1899.
7. Louis E., Mary J.Y., Vernier-Massouille G., et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012, 142:63-70. [e5; quiz e31].
8. Black S., Kushner I., Samols D. C-reactive protein. J Biol Chem 2004, 279:48487-48490.
9. Peyrin-Biroulet L., Gonzalez F., Dubuquoy L., et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012, 61:78-85.
10. Boussac M., Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000, 21:665-672.
11. Rammes A., Roth J., Goebeler M., Klempt M., Hartmann M., Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997, 272:9496-9502.
12. Voganatsi A., Panyutich A., Miyasaki K.T., Murthy R.K. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001, 70:130-134.